Jilin Aodong Pharmaceutical Group Co Ltd Class A 000623
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- CNY 15.24
- Day Range
- CNY 14.77–14.99
- 52-Week Range
- CNY 13.13–18.17
- Bid/Ask
- CNY 14.88 / CNY 14.89
- Market Cap
- CNY 17.81 Bil
- Volume/Avg
- 22.4 Mil / 14.5 Mil
Key Statistics
- Price/Earnings (Normalized)
- 13.77
- Price/Sales
- 4.93
- Dividend Yield (Trailing)
- 2.01%
- Dividend Yield (Forward)
- 2.01%
- Total Yield
- 2.01%
Company Profile
Jilin Aodong Pharmaceutical Group Co Ltd is engaged in manufacturing of pharmaceuticals. Its products include Anshen Bunao Liquid, Antelope Cough Syrup, Yangxue Yin Oral Liquid, Xinnao Shutong Capsule, Calf Spleen Extract Injection, Xuefu Zhuyu Oral Liquid, and others.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Mid Value
- Total Number of Employees
- 5,646
- Website
- http://www.jlaod.com
Comparables
Valuation
|
Metric
|
000623
|
600557
|
300016
|
|---|---|---|---|
Price/Earnings (Normalized) | 13.77 | 21.90 | — |
Price/Book Value | 0.65 | 2.15 | 1.46 |
Price/Sales | 4.93 | 2.33 | 2.63 |
Price/Cash Flow | 60.89 | 8.72 | 41.36 |
Price/Earnings
000623
600557
300016
Financial Strength
|
Metric
|
000623
|
600557
|
300016
|
|---|---|---|---|
Quick Ratio | 1.32 | 2.19 | 2.84 |
Current Ratio | 1.60 | 2.52 | 3.76 |
Interest Coverage | 7.69 | — | −0.39 |
Quick Ratio
000623
600557
300016
Profitability
|
Metric
|
000623
|
600557
|
300016
|
|---|---|---|---|
Return on Assets (Normalized) | 3.56% | 7.20% | −2.34% |
Return on Equity (Normalized) | 4.21% | 9.86% | −3.88% |
Return on Invested Capital (Normalized) | 4.09% | 9.16% | −1.18% |
Return on Assets
000623
600557
300016
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Zlbygnxg | Qnpq | $76.2 Bil | |
MKKGY
| Merck KGaA ADR | Pbrfxbnyq | Dtdktj | $70.9 Bil | |
HLN
| Haleon PLC ADR | Rbkjpsc | Wmlp | $37.8 Bil | |
VTRS
| Viatris Inc | Xgvjpkxh | Jpk | $14.0 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Lzdffcpjp | Mfqr | $12.7 Bil | |
CTLT
| Catalent Inc | Tnwcdlls | Lzzvspl | $10.2 Bil | |
PRGO
| Perrigo Co PLC | Pdfgsrk | Cqh | $4.4 Bil | |
CURLF
| Curaleaf Holdings Inc | Fbnrwxz | Wbvd | $4.1 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Xhzcclpz | Ddsxqc | $3.5 Bil | |
GTBIF
| Green Thumb Industries Inc | Fbbqscyhb | Zzqqf | $3.1 Bil |